Charles Bovaird

Charles Bovaird

Charles Bovaird is a Financial Writer and Consultant with strong knowledge of securities markets and investing concepts. He has worked for financial institutions including State Street, Moody's Analytics and Citizens Commercial Banking. 

An author of 500+ publications, his work has appeared in publications including Forbes, Washington Post and Fortune. 

Mr. Bovaird created all the industrial finance training for a company with 300+ people and has given speeches on financial literacy for Mensa and Boston Rotaract.

  1. Stocks

    Amazon's, Microsoft's Cloud Wars Truce Boosts Revenue

    Technology firms have been enjoying revenue growth.
  2. Stocks

    The Bull Case for Apple

    Apple shares could extend recent gains.
  3. Stocks

    Airline Stocks Soar Despite Irate Passengers

    Airline stocks have been soaring in spite of customer scandals.
  4. Stocks

    Hotel, Cruise Stocks Are Booming Amid Trump Travel Ban

    Hotel, casino and cruise line stocks have been surging.
  5. Markets & Economy

    Why Oil Could Rise 35% Before Year-End: Citigroup

    Crude could rise to $60 this year, says analyst Eric Lee.
  6. Stocks

    Intel, Nvidia Face Chipmaking Threat From Google

    Major chipmakers could face headwinds from Google.
  7. Stocks

    6 More Stocks With High Returns in an Uncertain Market

    Consumer staples could offer strong returns amid tepid growth.
  8. Stocks

    Wal-Mart, Costco Will Outperform in Face of Amazon

    Wal-Mart and Costco could thrive as broader retail struggles.
  9. Stocks

    3 Big Cap Winners: How Revenues Are Fueling These Stocks

    Investors might find gains in large cap stocks with strong fundamentals.
  10. Stocks

    Why the S&P May Outperform in 2017 Amid Turmoil

    The S&P 500 index could push higher this year.
  11. Stocks

    Gundlach Sees Big Market Drop, Says Raise Cash

    Stock speculators should raise cash, says Jeffrey Gundlach.
  12. Stocks

    Apple and Pfizer's Tax Windfall (AAPL, PFE, MSFT)

    Apple and Pfizer could enjoy multi-billion dollar one-time tax windfalls.
  13. Stocks

    Six Trends That Could Hammer the Markets (SPX, DJIA)

    Stocks face six major threats.
  14. Stocks

    S&P Will Jump 11%, Then Face a Bleak 2018, MS Says (SPX)

    How much higher can stocks climb?
  15. Stocks

    How Trump's Travel Ban Could Cost U.S. $18 Billion (DAL, AAL)

    Trump's travel ban could cost U.S. tourism $18 billion.